India APIs Incentive Scheme: Will It Galvanize Local Firms, Bridle The Dragon?
Aims To Improve Self-Sufficiency
Executive Summary
India shapes new production-linked incentives scheme for critical APIs to ensure self-reliance and cut massive dependence on imports from China, but much will depend on actual implementation, including timely clearances. Pharma will also need to 'walk the talk' alongside.
You may also be interested in...
India-Japan Partnering Momentum: Regulatory Alignment Is Key
Biopharma executives from India and Japan discuss the need for enhanced “alignment” on the regulatory front, including exploring the possibility of a mutual recognition agreement as the two nations seek to expand biopharma partnering efforts and also build supply chain resilience.
Supply Chain Crunch Meets Olympics Shutdown: China, India Drug Makers Brace For Perfect Storm
To ensure the Beijing Winter Olympics is a smooth affair, the Chinese government has ordered partial or complete halts in industrial production in some provinces from late November until mid-March, disrupting an already fragile active ingredient supply chain.
Supply Chain Crunch Meets Olympics Shutdown: China, India Drug Makers Embrace For Perfect Storm
To ensure the Beijing Winter Olympics is a smooth affair, the Chinese government has ordered partial or complete halts in industrial production in some provinces from late November until mid-March, disrupting an already fragile global pharma active ingredient supply chain. The emergence of the Omicron coronavirus variant is just adding to the complexities.